Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
18.95
-0.07 (-0.37%)
At close: Mar 13, 2026, 4:00 PM EDT
18.93
-0.02 (-0.11%)
After-hours: Mar 13, 2026, 5:17 PM EDT

Eton Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
37.1214.9421.3916.3114.4121.3
Cash & Short-Term Investments
37.1214.9421.3916.3114.4121.3
Cash Growth
83.21%-30.17%31.17%13.18%-32.35%76.49%
Accounts Receivable
13.085.363.411.855.470.05
Inventory
16.8615.230.910.560.551.24
Other Current Assets
4.945.491.131.293.182.12
Total Current Assets
7241.0226.842023.624.7
Net Property, Plant & Equipment
0.610.210.150.260.221
Other Intangible Assets
31.8834.884.744.753.620.58
Other Long-Term Assets
0.020.010.010.010.020.04
Total Assets
104.5176.1231.7425.0327.4726.32
Accounts Payable
14.264.171.851.771.772.34
Accrued Expenses
27.1515.789.013.661.371.17
Short-Term Debt
2.78----0.28
Current Portion of Long-Term Debt
--5.381.031.42-
Total Current Liabilities
44.1819.9516.246.464.563.79
Long-Term Debt
27.5929.81-5.385.266.76
Long-Term Leases
0.480.110.020.110.020.1
Other Long-Term Liabilities
9.131.83----
Total Long-Term Liabilities
37.231.750.025.495.286.86
Total Liabilities
81.3851.716.2611.959.8410.66
Common Stock
0.030.030.030.030.030.02
Additional Paid-in Capital
137.08132.29119.52116.19111.72107.8
Retained Earnings
-113.98-107.89-104.07-103.13-94.11-92.16
Shareholders' Equity
23.1324.4315.4813.0817.6315.66
Total Liabilities & Equity
104.5176.1231.7425.0327.4726.32
Total Debt
30.8529.925.46.526.77.14
Net Cash (Debt)
6.27-14.9815.999.787.7114.15
Net Cash Growth
--63.44%26.85%-45.52%88.53%
Net Cash Per Share
0.23-0.580.620.390.310.67
Book Value
23.1324.4315.4813.0817.6315.66
Book Value Per Share
0.870.940.600.520.700.75
Tangible Book Value
-8.75-10.4510.748.3214.0115.09
Tangible Book Value Per Share
-0.33-0.400.420.330.560.72
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q